Testing effectiveness (Phase 2)Study completedNCT04000737
What this trial is testing
YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC)
Who this might be right for
Advanced Hepatocellular Carcinoma
Yiviva Inc. 62